Spectral MD Holdings to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I SPAC
Spectral MD Holdings, Ltd. announced on April 11 that it has entered into an agreement to combine with Rosecliff Acquisition Corp I, a special purpose acquisition company (SPAC) listed on Nasdaq. The combined company expects to operate under the name Spectral AI and to be listed on Nasdaq under the symbol “MDAI”. The combined company will operate under the same management team, led by Spectral MD founder and CEO Wensheng Fan with current Spectral MD shareholders rolling 100% of their equity into the transaction. Net proceeds of the proposed transaction will be used to accelerate readiness for material potential federal contracts, to enhance Spectral MD’s efforts for broad... Read More »
Quest Diagnostics Completes Acquisition of Northern Light Laboratory
Quest Diagnostics announced on March 20 the completion of its acquisition of select assets of Northern Light Laboratory, the outreach laboratory services business of Northern Light Health, a large integrated healthcare system in Maine. The collaboration between the two parties is expected to enable physicians and patients throughout Maine to benefit from access to Quest’s test menu, network of patient access sites throughout the state, broad health plan coverage and lower out-of-pocket costs for many services. Quest’s laboratory in Marlborough, Massachusetts will provide the majority of advanced and routine clinical testing services for physicians and patients previously served... Read More »
Calibre Scientific Acquires AlphaScience
Calibre Scientific has announced its acquisition of AlphaScience GmbH, a diagnostics provider with its headquarters in Frankfurt, Germany. AlphaScience will be integrated with BIOZOL Diagnostica GmbH, a subsidiary of Calibre Scientific. With this acquisition, BIOZOL further enhances its position in the German research and diagnostics market, as AlphaScience brings new supplier relationships and product expertise that complement BIOZOL’s capabilities. Terms of the deal were not disclosed. AlphaScience is a provider of consumables and equipment for the commercial lab, clinical lab, academic, research and hospital industries. The company’s diagnostics product portfolio covers end-market... Read More »
Thermo Fisher Scientific: Leading the Diagnostic M&A Market With An Aggressive Acquisition Strategy
With 68 diagnostic M&A deals reported throughout 2022, many predicted the demand for the specialty would slow and, possibly, return to its pre-COVID-19 deal volume. Yet, the first few months of 2023 are showing higher than pre-COVID deal numbers. According to data captured in the LevinPro HC database, with 14 acquisitions the diagnostic market accounts for 56% of the 2023 Laboratories, MRI and Dialysis M&A market. In the same time frame of 2022, 25 diagnostic acquisitions were reported, accounting for more than 84%. The most active type of buyer is other laboratories, representing 43% of the diagnostic buyers. And most of the acquirers are public companies, also totaling... Read More »Panoramic Health Acquires North Shepherd Dialysis Access Center
Panoramic Health announced on March 10 that it acquired Houston-based North Shepherd Dialysis Access Center. This acquisition was announced alongside Panoramic Health’s partnership with Nephrology, Dialysis & Transplantation Associates, P.A. at The Kidney Institute. Panoramic Health plans to convert the North Shepherd Dialysis Access Center into a fully licensed ambulatory surgical center. The financial terms of the acquisition were not disclosed. Panoramic Health is a physician-led, value-based kidney care organization. Panoramic Health’s Clinical Research division partners with sponsors and clinical research organizations to bring cutting-edge treatments to patients with... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
